Location:

Local - New York Metro

Add to Favorites | Subscribe | Share

Filters:

  • (Press "esc" to clear)

Medicine

Channels:

Kidney Damage Diagnosis May Be Inaccurate for Many, Suggests Study

An analysis of patient records reveals that, for many, an initial diagnosis of “acute kidney injury” using current clinical diagnostic methods may have been inaccurate.

Science

Channels:

Government of Myanmar Unveils New Plan To Protect Marine Wildlife and Resources

7_RS15713_IMG_3088_1-lprSawHtooThaPoWCS.jpg

The Government of Myanmar and WCS (Wildlife Conservation Society) announced today a comprehensive plan to protect the country’s diverse fisheries and marine life—including dolphins, sea turtles, and other species—and other marine resources.

Medicine

Channels:

Heart Disease, Women and Heart Attacks , Women And Heart Disease, stress and heart attack, stress and heart disease, Mindfulness

CRF's Next Mini-Med School for Women Will Focus on Stress and Heart Disease

CRF’s next Mini-Med School for Women will cover the role stress plays in heart disease, and ways to manage stress for optimal health. The seminar is part of the CRF Women’s Heart Health Initiative which aims to reduce gender disparity in cardiovascular care through research and education. These Mini-Med School seminars feature leading experts who give New York area women the tools to take better care of themselves and their loved ones.

Medicine

Channels:

Amyloid, Amyloid Fibrils, Fibrils, Staphylococcus Aureus, Staphylococcus Aureus (Mrsa), Staphylococcus, MRSA, antibiotic resisistance, Antibiotics

Novel Amyloid Structure Could Lead to New Types of Antibiotics

Researchers have discovered unique amyloid fibers used by the highly drug resistant Staphylococcus aureus bacterium (which causes MRSA). The findings could lead to new types of antibiotics with a novel mechanism of action for attacking bacterial toxins.

Medicine

Channels:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 7-Mar-2017 6:00 AM EST

Medicine

Channels:

Rheumatoid Arthritis, RA, Rheumatoid Arthritis Remission, Rheumatoid Arthritis Medication, Autoantibodies, Autoimmune Disease And Disorder, B Cells, Tumor Necrosis Factor, anti-citrullinated protein antibodies, ACPA, Methotrexate

New Assay May Lead to a Cure for Debilitating Inflammatory Joint Disease

gregg-silverman-hero-crop.jpg

Current treatments for rheumatoid arthritis relieve the inflammation that leads to joint destruction, but the immunologic defect that triggers the inflammation persists to cause relapses. Now the results of a new study suggest that clinical trials for new rheumatoid arthritis (RA) drugs should shift from their sole focus on relieving inflammation to eliminating the B cells that produce these antibodies.

Science

Channels:

zika, Retina, Vision, Blindness

Wayne State Vision Researchers Show Zika Virus Can Damage Retina and Cause Blindness

Scientists at the Wayne State University School of Medicine Department of Ophthalmology at the Kresge Eye Institute have shown that the Zika virus can replicate in the eye’s retinal cells, causing severe tissue damage and even blindness. The research is supported in part by Research to Prevent Blindness.

Science

Channels:

National Academy of Engineering, NAE, Computer Science, Computational linguistics, prosody, Language, Columbia Engineering, Julia Hirschberg

Julia Hirschberg Elected to the National Academy of Engineering

HirschbergNAE.jpg

Professor Julia Hirschberg has been elected to the National Academy of Engineering (NAE), one of the highest professional distinctions awarded to an engineer. Hirschberg was cited by the NAE for her “contributions to the use of prosody in text-to-speech and spoken dialogue systems, and to audio browsing and retrieval.” Her research in speech analysis uses machine learning to help experts identify deceptive speech, and even to assess sentiment and emotion across languages and cultures.

Medicine

Channels:

Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, Diabetes, diabetic kidney disease

Diabetic Kidney Disease Is Decoded, Offering New Avenues for Diagnosis and Treatment

Mount Sinai researchers say their study represents hope for a complication considered incurable and deadly

Life

Law and Public Policy

Channels:

Democracies’ Track Record in Addressing Inequality Is Thin, Political Scientists Conclude

Democratic government has historically had little impact on wealth inequality, NYU’s David Stasavage and Stanford’s Kenneth Scheve conclude in a new analysis.

Medicine

Channels:

Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, Angioedema, Clinical Trial, New England Journal Of Medicine, New England Journal of Medicine (NEJM), Hereditary Angioedema, Genetic Disorders

In Rare Disorder, Novel Agent Stops Swelling Before It Starts

Mount Sinai researcher who treats hereditary angioedema says the drug, a potential game changer, is being studied in larger clinical trial

Medicine

Channels:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 27-Feb-2017 4:00 AM EST

Medicine

Channels:

Cancer, Immunotherapy, CAR T cells, CRISP/Cas9, CRISPR, CAR T cell, Sloan Kettering, Memorial Sloan Kettering, Memorial Sloan Kettering Cancer Center, Michel Sadelain, Tumor, Cancer Research, genome editing, chimeric antigen receptor cells, chimeric antigen receptors

CAR T Cells More Powerful When Built With CRISPR, MSK Researchers Find

MSK researchers used the genome-editing tool CRISPR to create more potent chimeric antigen receptor (CAR) T cells that don't tire as easily when attacking cancer cells. The unexpected findings were published in the journal Nature on February 22 and underscore the potential of genome editing to advance immunotherapy for cancer.

Medicine

Channels:

New Spiritual Care Communication Board Helps ICU Patients Express Spiritual Needs

A new spiritual care communication board is helping patients in the intensive care unit (ICU) communicate their emotional and spiritual needs.

Science

Channels:

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Feb-2017 12:00 PM EST

Medicine

Channels:

Drugs That Alter Inhibitory Targets Offer Therapeutic Strategies for Autism, Schizophrenia

Researchers at SUNY Downstate recently discovered that an inhibitory brain receptor triggers synaptic pruning in adolescence. Drugs that selectively target these receptors, when administered during adolescence, can alter synapse number, with possible implications for the treatment of autism and schizophrenia.

Life

Education

Channels:

Four NYU Faculty Win Sloan Foundation Research Fellowships

Four New York University faculty have been awarded fellowships from the Alfred P. Sloan Foundation.

Life

Social and Behavioral Sciences

Channels:

PTSD, Conduct Disorder, Trauma, Teens, Youth, Psychology, Shabnam Javdani, NYU Steinhardt, NYU Steinhardt School of Culture, Education, and Human Development, New York University

Teens with PTSD and Conduct Disorder Have Difficulty Recognizing Facial Expressions

Adolescents with posttraumatic stress disorder (PTSD) symptoms are more likely to misidentify sad and angry faces as fearful, while teens with symptoms of conduct disorder tend to interpret sad faces as angry, finds a study led by NYU’s Steinhardt School.

Medicine

Channels:

Infectious Diseases, Aaas Fellow, Biomedical Sciences, Medical Eduction, Scientists, infectious microorganisms, Immunology, Biomedical Research, Aaas Public Engagement Fellows

NYITCOM’s Martinez Named AAAS Leshner Leadership Institute Public Engagement Fellow

BoxProfiles_MartinezLuis_Hero.jpg

Luis Martinez, Ph.D., is an infectious disease researcher selected as a Fellow in the second cohort of the AAAS Alan I. Leshner Leadership Institute for Public Engagement with Science.

Medicine

Channels:

Acute Myeloid Leukemia (AML), Cancer, Leukemia, Hematopoietic Stem Cell, FLT3, RUNX1

Tumor Suppressor Promotes Some Acute Myeloid Leukemias, Study Reveals

Behrens.jpg

Researchers in Germany have discovered that a tumor suppressor protein thought to prevent acute myeloid leukemia (AML) can actually promote a particularly deadly form of the disease. The study, “RUNX1 cooperates with FLT3-ITD to induce leukemia,” which will be published online February 17 in The Journal of Experimental Medicine, suggests that targeting this protein could be an effective treatment for certain AML patients.







Chat now!